Viewing Company
Company Name:
CANCER CAPITAL CORP.
CIK:
1130889
Phone:
None
Fiscal Year End:
None
Entity Type:
SIC:
-
Category Type:
Entity Name:
None
First Filing Date:
2011-08-04
Last Filing Date:
2024-11-21
SEC Filings
| Start | End | Frame | Filed | ACCN | Value | View |
|---|---|---|---|---|---|---|
| 2011-04-01 | 2011-06-30 | CY2010Q2 | 2011-08-04 | 0001023175-11-000416 | $ 6,150,000 | View |
| 2011-07-01 | 2011-09-30 | CY2010Q3 | 2011-10-31 | 0001010412-11-000577 | $ 6,150,000 | View |
| 2011-01-01 | 2011-12-31 | CY2010 | 2012-03-28 | 0001010412-12-000111 | $ 6,150,000 | View |
| 2012-01-01 | 2012-03-31 | CY2011Q1 | 2012-05-09 | 0001548123-12-000027 | $ 6,150,000 | View |
| 2012-04-01 | 2012-06-30 | CY2011Q2 | 2012-08-02 | 0001548123-12-000179 | $ 6,150,000 | View |
| 2012-07-01 | 2012-09-30 | CY2011Q3 | 2012-10-29 | 0001548123-12-000319 | $ 6,150,000 | View |
| 2012-01-01 | 2012-12-31 | CY2011 | 2013-03-27 | 0001548123-13-000075 | $ 6,150,000 | View |
| 2013-01-01 | 2013-03-31 | CY2012Q1 | 2013-05-03 | 0001548123-13-000156 | $ 6,150,000 | View |
| 2013-04-01 | 2013-06-30 | CY2012Q2 | 2013-08-09 | 0001554795-13-000426 | $ 6,150,000 | View |
| 2013-07-01 | 2013-09-30 | CY2012Q3 | 2013-11-12 | 0001554795-13-000674 | $ 6,150,000 | View |
| 2013-01-01 | 2013-12-31 | CY2012 | 2014-03-28 | 0001554795-14-000234 | $ 6,150,000 | View |
| 2014-01-01 | 2014-03-31 | CY2013Q1 | 2014-05-08 | 0001554795-14-000354 | $ 6,150,000 | View |
| 2014-04-01 | 2014-06-30 | CY2013Q2 | 2014-07-29 | 0001554795-14-000462 | $ 6,150,000 | View |
| 2014-07-01 | 2014-09-30 | CY2013Q3 | 2014-11-12 | 0001554795-14-000621 | $ 6,150,000 | View |
| 2014-01-01 | 2014-12-31 | CY2013 | 2015-02-24 | 0001554795-15-000077 | $ 6,150,000 | View |
| 2015-01-01 | 2015-03-31 | CY2014Q1 | 2015-05-11 | 0001554795-15-000179 | $ 6,150,000 | View |
| 2015-04-01 | 2015-06-30 | CY2014Q2 | 2015-08-11 | 0001554795-15-000302 | $ 6,150,000 | View |
| 2015-07-01 | 2015-09-30 | CY2014Q3 | 2015-10-30 | 0001554795-15-000412 | $ 6,150,000 | View |
| 2016-04-01 | 2016-06-30 | CY2015Q2 | 2016-08-08 | 0001554795-16-000776 | $ 6,150,000 | View |
| 2017-01-01 | 2017-12-31 | CY2016 | 2018-03-23 | 0001554795-18-000059 | $ 6,150,000 | View |
| 2018-01-01 | 2018-12-31 | CY2017 | 2019-03-19 | 0001554795-19-000061 | $ 6,150,000 | View |
| 2019-01-01 | 2019-03-31 | CY2018Q1 | 2019-05-10 | 0001554795-19-000125 | $ 6,150,000 | View |
| 2019-04-01 | 2019-06-30 | CY2018Q2 | 2019-08-09 | 0001554795-19-000236 | $ 6,150,000 | View |
| 2019-07-01 | 2019-09-30 | CY2018Q3 | 2019-11-12 | 0001554795-19-000371 | $ 6,150,000 | View |
| 2019-01-01 | 2019-12-31 | CY2018 | 2020-04-14 | 0001554795-20-000101 | $ 6,150,000 | View |
| 2020-01-01 | 2020-03-31 | CY2019Q1 | 2020-05-12 | 0001554795-20-000121 | $ 6,150,000 | View |
| 2020-04-01 | 2020-06-30 | CY2019Q2 | 2020-08-10 | 0001554795-20-000201 | $ 6,150,000 | View |
| 2016-07-01 | 2016-09-30 | CY2015Q3 | 2016-11-01 | 0001554795-16-000891 | $ 6,150,000 | View |
| 2016-01-01 | 2016-12-31 | CY2015 | 2017-03-20 | 0001554795-17-000097 | $ 6,150,000 | View |
| 2017-01-01 | 2017-03-31 | CY2016Q1 | 2017-05-05 | 0001554795-17-000189 | $ 6,150,000 | View |
| 2017-04-01 | 2017-06-30 | CY2016Q2 | 2017-08-08 | 0001554795-17-000322 | $ 6,150,000 | View |
| 2017-07-01 | 2017-09-30 | CY2016Q3 | 2017-11-09 | 0001554795-17-000389 | $ 6,150,000 | View |
| 2018-01-01 | 2018-03-31 | CY2017Q1 | 2018-05-10 | 0001554795-18-000117 | $ 6,150,000 | View |
| 2018-04-01 | 2018-06-30 | CY2017Q2 | 2018-08-09 | 0001554795-18-000203 | $ 6,150,000 | View |
| 2018-07-01 | 2018-09-30 | CY2017Q3 | 2018-11-06 | 0001554795-18-000314 | $ 6,150,000 | View |
| 2020-07-01 | 2020-09-30 | CY2019Q3 | 2020-11-06 | 0001554795-20-000286 | $ 6,150,000 | View |
| 2020-01-01 | 2020-12-31 | CY2019 | 2021-03-25 | 0001554795-21-000089 | $ 6,150,000 | View |
| 2021-01-01 | 2021-03-31 | CY2021Q1 | 2021-05-17 | 0001554795-21-000187 | $ 6,150,000 | View |
| 2021-04-01 | 2021-06-30 | CY2021Q2 | 2021-08-13 | 0001554795-21-000281 | $ 6,150,000 | View |
| 2021-07-01 | 2021-09-30 | CY2021Q3 | 2021-11-05 | 0001554795-21-000381 | $ 6,150,000 | View |
| 2022-01-01 | 2022-03-31 | CY2021Q1 | 2022-05-13 | 0001554795-22-000184 | $ -5,088 | View |
| 2022-04-01 | 2022-06-30 | CY2021Q2 | 2022-08-12 | 0001554795-22-000287 | $ -5,408 | View |
| 2022-07-01 | 2022-09-30 | CY2021Q3 | 2022-11-03 | 0001554795-22-000364 | $ -5,448 | View |
| 2021-01-01 | 2021-12-31 | CY2021 | 2022-03-22 | 0001554795-22-000107 | $ 6,150,000 | View |
| 2022-01-01 | 2022-12-31 | CY2020Q4I | 2023-03-30 | 0001554795-23-000097 | $ 22,055 | View |
| 2023-01-01 | 2023-03-31 | CY2022Q1I | 2023-05-03 | 0001554795-23-000131 | $ 17,856 | View |
| 2023-07-01 | 2023-09-30 | CY2022Q3I | 2023-11-02 | 0001554795-23-000336 | $ 15,057 | View |
| 2023-01-01 | 2023-12-31 | CY2023 | 2024-04-15 | 0001554795-24-000087 | $ 16,157 | View |
| 2024-01-01 | 2024-03-31 | CY2024Q1I | 2024-05-09 | 0001554795-24-000126 | $ 12,657 | View |
| 2024-04-01 | 2024-06-30 | CY2024Q2I | 2024-08-14 | 0001554795-24-000204 | $ 5,157 | View |
| 2024-07-01 | 2024-09-30 | CY2024Q3I | 2024-11-21 | 0001554795-24-000317 | $ 4,109 | View |
| 2022-01-01 | 2022-06-30 | CY2022Q2I | 2023-08-03 | 0001554795-23-000237 | $ 1,350 | View |
| 2015-01-01 | 2015-12-31 | CY2014 | 2016-03-22 | 0001554795-16-000580 | $ 6,150,000 | View |
| 2016-01-01 | 2016-03-31 | CY2015Q1 | 2016-05-13 | 0001554795-16-000680 | $ 6,150,000 | View |
SEC Facts By Type
| Type | Name | Description | View |
|---|---|---|---|
| dei | Entity Common Stock, Shares Outstanding | Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument. | View |
| us-gaap | Additional Paid in Capital | Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock. | View |
| us-gaap | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. | View |
| us-gaap | Cash and Cash Equivalents, Period Increase (Decrease) | Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes. | View |
| us-gaap | Deferred Tax Assets, Net | Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting. | View |
| us-gaap | Earnings Per Share, Basic and Diluted | The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | View |
| us-gaap | Increase (Decrease) in Due from Related Parties, Current | The aggregate increase (decrease) during the reporting period in the amount due from the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence. | View |
| us-gaap | Increase (Decrease) in Notes Payable, Related Parties | The increase (decrease) during the reporting period in the amount owed by the reporting entry in the form of loans and obligations (generally evidenced by promissory notes) made by the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management, an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence. | View |
| us-gaap | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. | View |
| us-gaap | Revenues | Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). | View |
| us-gaap | Stockholders' Equity Attributable to Parent | Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. | View |
| dei | Entity Public Float | The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter. | View |
| us-gaap | Accounts Payable (Deprecated 2009-01-31) | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. For classified balance sheets, used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer); for unclassified balance sheets, used to reflect the total liabilities (regardless of due date). | View |
| us-gaap | Accounts Payable and Accrued Liabilities, Current | Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits. | View |
| us-gaap | Accounts Payable and Other Accrued Liabilities | Amount of liabilities incurred and payable to vendors for goods and services received, and accrued liabilities classified as other. | View |
| us-gaap | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). | View |
| us-gaap | Accounts Payable, Interest-bearing, Interest Rate | Reflects the effective interest rate as of the balance sheet date on interest-bearing trade payables. | View |
| us-gaap | Accounts Payable, Related Parties, Current | Amount for accounts payable to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). | View |
| us-gaap | Accounts Payable, Related Parties | Amount for accounts payable to related parties. | View |
| us-gaap | Accrued Liabilities and Other Liabilities | Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other. | View |
| us-gaap | Accrued Liabilities, Current | Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). | View |
| us-gaap | Accrued Liabilities | Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. | View |
| us-gaap | Accrued Professional Fees | Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. | View |
| us-gaap | Adjustments to Additional Paid in Capital, Other | Amount of other increase (decrease) in additional paid in capital (APIC). | View |
| us-gaap | Assets | Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. | View |
| us-gaap | Assets, Current | Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. | View |
| us-gaap | Banking Regulation, Total Capital, Actual | Amount of total capital as defined by regulatory framework. | View |
| us-gaap | Deferred Tax Assets, Gross | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. | View |
| us-gaap | Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes effect from exchange rate changes. | View |
| us-gaap | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. | View |
| us-gaap | Cash Equivalents, at Carrying Value | Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. | View |
| us-gaap | Cash, Period Increase (Decrease) | Amount of increase (decrease) in cash. Cash is the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Includes effect from exchange rate changes. | View |
| us-gaap | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | View |
| us-gaap | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | View |
| us-gaap | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | View |
| us-gaap | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | View |
| us-gaap | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. | View |
| us-gaap | Common Stock, Value, Outstanding | Value of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares. | View |
| us-gaap | Concentration Risk, Percentage | "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the ""benchmark"" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." | View |
| us-gaap | Costs and Expenses | Total costs of sales and operating expenses for the period. | View |
| us-gaap | Costs and Expenses, Related Party | Costs of sales and operating expenses for the period incurred from transactions with related parties. | View |
| us-gaap | Current Federal Tax Expense (Benefit) | Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations. | View |
| us-gaap | Current Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations. | View |
| us-gaap | Current State and Local Tax Expense (Benefit) | Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations. | View |
| us-gaap | Debt Instrument, Increase, Accrued Interest | Increase for accrued, but unpaid interest on the debt instrument for the period. | View |
| us-gaap | Debt Instrument, Interest Rate at Period End (Deprecated 2014-01-31) | The effective interest rate at the end of the reporting period. | View |
| us-gaap | Debt Instrument, Interest Rate During Period | The average effective interest rate during the reporting period. | View |
| us-gaap | Debt Instrument, Interest Rate, Stated Percentage | Contractual interest rate for funds borrowed, under the debt agreement. | View |
| us-gaap | Deferred Tax Assets, Net of Valuation Allowance | Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. | View |
| us-gaap | Deferred Tax Assets, Operating Loss Carryforwards | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. | View |
| us-gaap | Deferred Tax Assets, Tax Credit Carryforwards | Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards. | View |
| us-gaap | Deferred Tax Assets, Valuation Allowance | Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. | View |
| us-gaap | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) | Cumulative net losses reported during the development stage. | View |
| us-gaap | Due to Related Parties (Deprecated 2009-01-31) | Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer). For unclassified balance sheets, represents the total of such liabilities. | View |
| us-gaap | Due to Related Parties, Current | Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer). | View |
| us-gaap | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | View |
| us-gaap | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. | View |
| us-gaap | Income (Loss) from Continuing Operations before Income Taxes, Domestic | The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations. | View |
| us-gaap | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. | View |
| us-gaap | Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31) | The sum of the current income tax expense or benefit and the deferred income tax expense or benefit pertaining to pretax Income or Loss from continuing operations; income tax expense or benefit may include interest and penalties on tax uncertainties based on the entity's accounting policy. | View |
| us-gaap | Income Taxes Paid | The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets. | View |
| us-gaap | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments. | View |
| us-gaap | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. | View |
| us-gaap | Increase (Decrease) in Accounts Payable and Accrued Liabilities | The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. | View |
| us-gaap | Increase (Decrease) in Accrued Interest Receivable, Net | The increase (decrease) during the reporting period in the amount due from borrowers for interest payments. | View |
| us-gaap | Increase (Decrease) in Due from Related Parties | The increase (decrease) during the reporting period in receivables to be collected from other entities that could exert significant influence over the reporting entity. | View |
| us-gaap | Retained Earnings (Accumulated Deficit) | The cumulative amount of the reporting entity's undistributed earnings or deficit. | View |
| us-gaap | Increase (Decrease) in Due to Other Related Parties | Amount of increase (decrease) in related party payables classified as other. | View |
| us-gaap | Increase (Decrease) in Due to Other Related Parties, Current | Amount of increase (decrease) in related party payables classified as other, due within one year or operating cycle, if longer. | View |
| us-gaap | Increase (Decrease) in Due to Related Parties | The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence. | View |
| us-gaap | Increase (Decrease) in Due to Related Parties, Current | The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence. | View |
| us-gaap | Increase (Decrease) in Interest Payable, Net | The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity. | View |
| us-gaap | Increase (Decrease) in Notes Payable, Current | The increase (decrease) during the reporting period in current portion (due within one year or one business cycle) of obligations evidenced by formal promissory notes. | View |
| us-gaap | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities | The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid. | View |
| us-gaap | Interest Expense | Amount of the cost of borrowed funds accounted for as interest expense. | View |
| us-gaap | Interest Expense, Related Party | Amount of interest expense incurred on a debt or other obligation to related party. | View |
| us-gaap | Interest Paid, Including Capitalized Interest, Operating and Investing Activities | Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities. | View |
| us-gaap | Interest Payable (Deprecated 2009-01-31) | Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. For classified balance sheets, used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer); for unclassified balance sheets, used to reflect the total liabilities (regardless of due date). | View |
| us-gaap | Interest Payable, Current | Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). | View |
| us-gaap | Issuance of Stock and Warrants for Services or Claims | Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims. | View |
| us-gaap | Liabilities | Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. | View |
| us-gaap | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. | View |
| us-gaap | Liabilities Assumed | The fair value of liabilities assumed in noncash investing or financing activities. | View |
| us-gaap | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. | View |
| us-gaap | Loans Payable | Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer). | View |
| us-gaap | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. | View |
| us-gaap | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | View |
| us-gaap | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. | View |
| us-gaap | Noncash or Part Noncash Acquisition, Debt Assumed | "The amount of debt that an Entity assumes in acquiring a business or in consideration for an asset received in a noncash (or part noncash) acquisition. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." | View |
| us-gaap | Notes Payable | Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer. | View |
| us-gaap | Notes Payable, Current | Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer. | View |
| us-gaap | Notes Payable, Related Parties, Current | The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). | View |
| us-gaap | Notes Payable, Related Parties | The amount for notes payable (written promise to pay), due to related parties. | View |
| us-gaap | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. | View |
| us-gaap | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. | View |
| us-gaap | Operating Loss Carryforwards | Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. | View |
| us-gaap | Operating Loss Carryforwards, Valuation Allowance | The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized. | View |
| us-gaap | Other Cost and Expense, Operating | The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation. | View |
| us-gaap | Other Expenses | Amount of expense classified as other. | View |
| us-gaap | Other Income | Amount of revenue and income classified as other. | View |
| us-gaap | Other Notes Payable | Amount of long-term notes payable classified as other. | View |
| us-gaap | Other Notes Payable, Current | Amount of long-term notes classified as other, payable within one year or the normal operating cycle, if longer. | View |
| us-gaap | Other Operating Income (Expense), Net | The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations. | View |
| us-gaap | Other Significant Noncash Transaction, Value of Consideration Given | "The value of the noncash (or part noncash) consideration given (for example, liability, equity) in a transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. ""Part noncash"" refers to that portion of a transaction not resulting in cash receipts or cash payments in the period." | View |
| us-gaap | Proceeds from Issuance of Common Stock | The cash inflow from the additional capital contribution to the entity. | View |
| us-gaap | Proceeds from Issuance of Other Long-term Debt | Amount of cash inflow from issuance of long-term debt classified as other. | View |
| us-gaap | Proceeds from Loans | Cash received from principal payments made on loans related to operating activities. | View |
| us-gaap | Proceeds from Notes Payable | The cash inflow from a borrowing supported by a written promise to pay an obligation. | View |
| us-gaap | Proceeds from Related Party Debt | The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates. | View |
| us-gaap | Proceeds from (Repayments of) Short-term Debt | The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer. | View |
| us-gaap | Related Party Transaction, Expenses from Transactions with Related Party | Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party. | View |
| us-gaap | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | View |
| us-gaap | Stock Issued (Deprecated 2011-01-31) | The fair value of stock issued in noncash financing activities. | View |
| us-gaap | Stock Issued | The fair value of stock issued in noncash financing activities. | View |
| us-gaap | Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) | Number of shares issued as consideration for cash for development stage entities. | View |
| us-gaap | Stock Issued During Period, Shares, Issued for Services | Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders. | View |
| us-gaap | Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture | Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP). | View |
| us-gaap | Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) | Value of shares issued as consideration for cash for development stage entities. | View |
| us-gaap | Stock Issued During Period, Value, Issued for Services | Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders. | View |
| us-gaap | Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). | View |
| us-gaap | Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions | Amount of decrease in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return. | View |
| us-gaap | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions | Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns. | View |
| us-gaap | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return. | View |
| us-gaap | Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns. | View |
| us-gaap | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset. | View |
| us-gaap | SEC Schedule, 12-09, Valuation Allowances and Reserves, Period Increase (Decrease) | Amount of increase (decrease) in valuation and qualifying accounts and reserves. | View |
| us-gaap | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. | View |
| us-gaap | Other Nonoperating Income (Expense) | Amount of income (expense) related to nonoperating activities, classified as other. | View |
| us-gaap | Weighted Average Number of Shares Outstanding, Basic and Diluted | Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). | View |
| us-gaap | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. | View |
| us-gaap | Increase (Decrease) in Accounts Payable and Other Operating Liabilities | Amount of increase (decrease) in obligations incurred but not paid, and operating obligations classified as other. | View |
Chart of Accounts => Accounts
| Name | View |
|---|---|
| Adjustments to Additional Paid in Capital, Other | View |
| Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | View |
| Development Stage Entities, Stock Issued, Shares, Issued for Cash (Deprecated 2015-01-31) | View |
| Additional Paid in Capital | View |
| Liabilities Assumed | View |
| Liabilities, Current | View |
| Loans Payable | View |
| Net Cash Provided by (Used in) Financing Activities | View |
| Net Cash Provided by (Used in) Investing Activities | View |
| Net Cash Provided by (Used in) Operating Activities | View |
| Net Income (Loss) Attributable to Parent | View |
| Noncash or Part Noncash Acquisition, Debt Assumed | View |
| Notes Payable | View |
| Notes Payable, Current | View |
| Notes Payable, Related Parties, Current | View |
| Notes Payable, Related Parties | View |
| Operating Expenses | View |
| Operating Income (Loss) | View |
| Operating Loss Carryforwards | View |
| Operating Loss Carryforwards, Valuation Allowance | View |
| Other Cost and Expense, Operating | View |
| Other Expenses | View |
| Other Income | View |
| Other Notes Payable | View |
| Other Notes Payable, Current | View |
| Other Operating Income (Expense), Net | View |
| Other Significant Noncash Transaction, Value of Consideration Given | View |
| Proceeds from Issuance of Common Stock | View |
| Proceeds from Issuance of Other Long-term Debt | View |
| Proceeds from Loans | View |
| Proceeds from Notes Payable | View |
| Proceeds from Related Party Debt | View |
| Proceeds from (Repayments of) Short-term Debt | View |
| Related Party Transaction, Expenses from Transactions with Related Party | View |
| Retained Earnings (Accumulated Deficit) | View |
| Revenues | View |
| Shares, Outstanding | View |
| Stockholders' Equity Attributable to Parent | View |
| Stock Issued (Deprecated 2011-01-31) | View |
| Stock Issued | View |
| Accounts Payable (Deprecated 2009-01-31) | View |
| Accounts Payable and Accrued Liabilities, Current | View |
| Accounts Payable and Other Accrued Liabilities | View |
| Accounts Payable, Current | View |
| Accounts Payable, Interest-bearing, Interest Rate | View |
| Accounts Payable, Related Parties, Current | View |
| Accounts Payable, Related Parties | View |
| Accrued Liabilities and Other Liabilities | View |
| Accrued Liabilities, Current | View |
| Accrued Liabilities | View |
| Accrued Professional Fees | View |
| Assets | View |
| Assets, Current | View |
| Banking Regulation, Total Capital, Actual | View |
| Cash and Cash Equivalents, at Carrying Value | View |
| Cash and Cash Equivalents, Period Increase (Decrease) | View |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | View |
| Cash Equivalents, at Carrying Value | View |
| Cash, Period Increase (Decrease) | View |
| Common Stock, Par or Stated Value Per Share | View |
| Common Stock, Shares Authorized | View |
| Common Stock, Shares, Issued | View |
| Common Stock, Shares, Outstanding | View |
| Common Stock, Value, Issued | View |
| Common Stock, Value, Outstanding | View |
| Concentration Risk, Percentage | View |
| Costs and Expenses | View |
| Costs and Expenses, Related Party | View |
| Current Federal Tax Expense (Benefit) | View |
| Current Income Tax Expense (Benefit) | View |
| Current State and Local Tax Expense (Benefit) | View |
| Debt Instrument, Increase, Accrued Interest | View |
| Debt Instrument, Interest Rate at Period End (Deprecated 2014-01-31) | View |
| Debt Instrument, Interest Rate During Period | View |
| Debt Instrument, Interest Rate, Stated Percentage | View |
| Deferred Tax Assets, Gross | View |
| Deferred Tax Assets, Net | View |
| Deferred Tax Assets, Net of Valuation Allowance | View |
| Deferred Tax Assets, Operating Loss Carryforwards | View |
| Deferred Tax Assets, Tax Credit Carryforwards | View |
| Deferred Tax Assets, Valuation Allowance | View |
| Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) | View |
| Due to Related Parties (Deprecated 2009-01-31) | View |
| Due to Related Parties, Current | View |
| Earnings Per Share, Basic | View |
| Earnings Per Share, Basic and Diluted | View |
| General and Administrative Expense | View |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | View |
| Income Tax Expense (Benefit) | View |
| Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31) | View |
| Income Taxes Paid | View |
| Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | View |
| Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | View |
| Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | View |
| Increase (Decrease) in Accounts Payable | View |
| Increase (Decrease) in Accounts Payable and Accrued Liabilities | View |
| Increase (Decrease) in Accrued Interest Receivable, Net | View |
| Increase (Decrease) in Due from Related Parties | View |
| Increase (Decrease) in Due from Related Parties, Current | View |
| Increase (Decrease) in Due to Other Related Parties | View |
| Increase (Decrease) in Due to Other Related Parties, Current | View |
| Increase (Decrease) in Due to Related Parties | View |
| Increase (Decrease) in Due to Related Parties, Current | View |
| Increase (Decrease) in Interest Payable, Net | View |
| Increase (Decrease) in Notes Payable, Current | View |
| Increase (Decrease) in Notes Payable, Related Parties | View |
| Increase (Decrease) in Other Accounts Payable and Accrued Liabilities | View |
| Interest Expense | View |
| Interest Expense, Related Party | View |
| Interest Paid, Including Capitalized Interest, Operating and Investing Activities | View |
| Interest Payable (Deprecated 2009-01-31) | View |
| Interest Payable, Current | View |
| Issuance of Stock and Warrants for Services or Claims | View |
| Liabilities | View |
| Liabilities and Equity | View |
| Stock Issued During Period, Shares, Issued for Services | View |
| Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture | View |
| Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) | View |
| Stock Issued During Period, Value, Issued for Services | View |
| Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | View |
| Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions | View |
| Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions | View |
| Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | View |
| Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | View |
| Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | View |
| SEC Schedule, 12-09, Valuation Allowances and Reserves, Period Increase (Decrease) | View |
| Weighted Average Number of Shares Outstanding, Basic | View |
| Other Nonoperating Income (Expense) | View |
| Weighted Average Number of Shares Outstanding, Basic and Diluted | View |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | View |
| Increase (Decrease) in Accounts Payable and Other Operating Liabilities | View |